Skip to main content
. 2015 Jul 29;6(29):27505–27518. doi: 10.18632/oncotarget.4752

Table 3. ERα and PR association with disease recurrence.

Variables All patients Patients with pT1a disease
N (%) 5-yr CIR P N (%) 5-yr CIR P
ERα nucleus 0.38 0.018
 Negative 756 (83) 17% 336 (81) 8%
 Positive 157 (17) 21% 81 (19) 20%
ERα cytoplasm 0.37 0.14
 Negative 827 (91) 18% 380 (91) 11%
 Positive 86 (9) 14% 37 (9) 5%
PR nucleus 0.18 0.96
 Negative 791 (87) 17% 347 (83) 10%
 Positive 119 (13) 23% 69 (17) 12%
PR cytoplasm 0.42 0.65
 Negative 794 (87) 18% 348 (84) 10%
 Positive 116 (13) 16% 68 (16) 10%

Significant P-values (<0.05) are shown in bold.

ER, estrogen receptor; PR, progesterone receptor; CIR, cumulative incidence of recurrence